PFN1 Gene Polymorphisms and the Bone Mineral Density Response to Alendronate Therapy in Postmenopausal Chinese Women with Low Bone Mass

PURPOSE: Alendronate is a widely used anti-osteoporotic drug. PFN1 gene is a newly identified early-onset Paget’s disease pathogenic gene. The purpose of this study is to study whether the genetic variations in this gene affect the clinical efficacy of alendronate in postmenopausal Chinese women wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jiao, Liu, Li, Lv, Shanshan, Wang, Chun, Yue, Hua, Zhang, Zhenlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711734/
https://www.ncbi.nlm.nih.gov/pubmed/34992429
http://dx.doi.org/10.2147/PGPM.S344818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8711734/
https://www.ncbi.nlm.nih.gov/pubmed/34992429
http://dx.doi.org/10.2147/PGPM.S344818

Ejemplares similares